Goldman Sachs Group Inc Immunocore Holdings PLC Call Options Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$60.14 - $75.36 $2.81 Million - $3.52 Million
46,700 New
46,700 $3.04 Million
Q3 2023

May 14, 2024
BUY
$49.5 - $66.6 $356,400 - $479,519
7,200 New
7,200 $373,000
Q3 2023

Nov 14, 2023
BUY
$49.5 - $66.6 $356,400 - $479,519
7,200 New
7,200 $373,000

Others Institutions Holding IMCR

# of Institutions
150
Shares Held
39.8M
Call Options Held
157K
Put Options Held
135K
View Full List

About Immunocore Holdings plc

IMCR Quotes by TradingView
  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.38B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email